In 2025, an unexpected surge in Butalbital prescription rise has caught the attention of both medical professionals and patients alike. Once criticized for its addictive potential, Fioricet—a combination of butalbital, acetaminophen, and caffeine—is now seeing a revival in prescription rates. In this article, we’ll explore the key factors driving this increase, its risks, and viable alternatives for those seeking relief from headaches and migraines.

Read more “Why Butalbital Prescription Rise Is on the Rise in 2025: Understanding the Trend”